Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minfeng Chen

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Expert Opinion on Therapeutic Targets|August 7, 2019
Targeting platelet-derived growth factor receptor β inhibits the proliferation and motility of human pterygial fibroblastsWeiqian Mai, Minfeng Chen, Maohua Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2016
Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapyJinbo Chen, Long Wang, Yunhua Tang, et al.
Bladder (San Francisco, Calif.)|September 11, 2025
Neoadjuvant therapy plus thulium laser transurethral bladder tumor resection for muscle-invasive bladder cancerHonglin Zhong, Wei He, Miao Mo, et al.
Journal of Optometry|August 31, 2025
Positive relative accommodation is an independent risk factor for myopia onset: a prospective cohort study among chinese primary schoolchildren, the WEPrOM studyYingying Ye, Yimin Yuan, Chengnan Guo, et al.
Pharmacological Research|December 28, 2022
Corrigendum to "Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin" Pharmacol. Res. Vol. 123 (2017) 130-142Liping Chen, Weiqian Mai, Minfeng Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer ImmunityZhiyong Cai, Jinbo Chen, Zhengzheng Yu, et al.
Pharmacological Research|May 4, 2019
Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathwayJiayan Zhang, Mingqun Liu, Maohua Huang, et al.
Theranostics|January 2, 2018
Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin InternalizationXueping Lei, Minfeng Chen, Maohua Huang, et al.
Acta Pharmaceutica Sinica. B|March 27, 2023
Erratum: Author correction to "The FAP<i>α</i>-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304]Geni Ye, Maohua Huang, Yong Li, et al.
American Journal of Cancer Research|February 13, 2023
Erratum: <i>In vitro</i> and <i>in vivo</i> antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathwaysXueping Lei, Minfeng Chen, Qiulin Nie, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Expert Opinion on Therapeutic Targets|August 7, 2019
Targeting platelet-derived growth factor receptor β inhibits the proliferation and motility of human pterygial fibroblastsWeiqian Mai, Minfeng Chen, Maohua Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2016
Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapyJinbo Chen, Long Wang, Yunhua Tang, et al.
Bladder (San Francisco, Calif.)|September 11, 2025
Neoadjuvant therapy plus thulium laser transurethral bladder tumor resection for muscle-invasive bladder cancerHonglin Zhong, Wei He, Miao Mo, et al.
Journal of Optometry|August 31, 2025
Positive relative accommodation is an independent risk factor for myopia onset: a prospective cohort study among chinese primary schoolchildren, the WEPrOM studyYingying Ye, Yimin Yuan, Chengnan Guo, et al.
Pharmacological Research|December 28, 2022
Corrigendum to "Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin" Pharmacol. Res. Vol. 123 (2017) 130-142Liping Chen, Weiqian Mai, Minfeng Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer ImmunityZhiyong Cai, Jinbo Chen, Zhengzheng Yu, et al.
Pharmacological Research|May 4, 2019
Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathwayJiayan Zhang, Mingqun Liu, Maohua Huang, et al.
Theranostics|January 2, 2018
Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin InternalizationXueping Lei, Minfeng Chen, Maohua Huang, et al.
Acta Pharmaceutica Sinica. B|March 27, 2023
Erratum: Author correction to "The FAP<i>α</i>-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304]Geni Ye, Maohua Huang, Yong Li, et al.
American Journal of Cancer Research|February 13, 2023
Erratum: <i>In vitro</i> and <i>in vivo</i> antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathwaysXueping Lei, Minfeng Chen, Qiulin Nie, et al.
Pageof 21